155 related articles for article (PubMed ID: 24531750)
21. A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice.
De Ruysscher D; Sobis H; Vandeputte M; Waer M
J Immunol; 1991 Jun; 146(12):4065-70. PubMed ID: 1828259
[TBL] [Abstract][Full Text] [Related]
22. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases.
Naumov GN; Townson JL; MacDonald IC; Wilson SM; Bramwell VH; Groom AC; Chambers AF
Breast Cancer Res Treat; 2003 Dec; 82(3):199-206. PubMed ID: 14703067
[TBL] [Abstract][Full Text] [Related]
23. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
Markovic SN; Murasko DM
Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
[TBL] [Abstract][Full Text] [Related]
24. In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones.
Algarra I; PĂ©rez M; Gaforio JJ; Gasca F; Garrido F
Clin Exp Metastasis; 1994 Jan; 12(1):31-6. PubMed ID: 8287618
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
[TBL] [Abstract][Full Text] [Related]
26. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
[TBL] [Abstract][Full Text] [Related]
27. Subsets of oncofetal antigen-induced T-cells: ability to mediate antitumor immune response.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1983 May; 70(5):923-30. PubMed ID: 6601736
[TBL] [Abstract][Full Text] [Related]
28. Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.
Dvorkin T; Song X; Argov S; White RM; Zoller M; Segal S; Dinarello CA; Voronov E; Apte RN
J Leukoc Biol; 2006 Jul; 80(1):96-106. PubMed ID: 16707560
[TBL] [Abstract][Full Text] [Related]
29. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
Naumov GN; MacDonald IC; Weinmeister PM; Kerkvliet N; Nadkarni KV; Wilson SM; Morris VL; Groom AC; Chambers AF
Cancer Res; 2002 Apr; 62(7):2162-8. PubMed ID: 11929839
[TBL] [Abstract][Full Text] [Related]
30. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of metastatic potential by gamma-interferon.
Kelly SA; Gschmeissner S; East N; Balkwill FR
Cancer Res; 1991 Aug; 51(15):4020-7. PubMed ID: 1906780
[TBL] [Abstract][Full Text] [Related]
32. Vaccination with IFN-inducible T cell alpha chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells.
Yang X; Chu Y; Wang Y; Guo Q; Xiong S
Vaccine; 2006 Apr; 24(15):2966-74. PubMed ID: 16503368
[TBL] [Abstract][Full Text] [Related]
33. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
Callahan GN
J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
[TBL] [Abstract][Full Text] [Related]
34. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
35. Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases.
Lewis JD; Shearer MH; Kennedy RC; Bright RK
Cancer Res; 2005 Apr; 65(7):2938-46. PubMed ID: 15805297
[TBL] [Abstract][Full Text] [Related]
36. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
37. Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors.
Chou T; Bertera S; Chang AE; Shu S
J Immunol; 1988 Sep; 141(5):1775-81. PubMed ID: 3261761
[TBL] [Abstract][Full Text] [Related]
38. Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selection.
De Giovanni C; Lollini PL; Nicoletti G; Del Re B; Scotlandi K; Prodi G; Nanni P
Exp Clin Immunogenet; 1987; 4(3):153-62. PubMed ID: 3273420
[TBL] [Abstract][Full Text] [Related]
39. Effect of protein kinase C activating tumor promoters on metastases formation by fibrosarcoma cells.
Isakov N; Gopas J; Priel E; Segal S; Altman A
Invasion Metastasis; 1991; 11(1):14-24. PubMed ID: 2061000
[TBL] [Abstract][Full Text] [Related]
40. Enhanced experimental metastasis of ultraviolet light-induced fibrosarcomas in ultraviolet light-irradiated syngeneic mice.
Kripke ML; Fidler IJ
Cancer Res; 1980 Mar; 40(3):625-9. PubMed ID: 6451287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]